Even as coronavirus cases across the world continue to plummet in a dangerous way, a novel vaccine developed by the University of Sechenov, Russia might be one of the first of its kind to be effective against coronavirus, as researchers have claimed to have completed the work on clinical trials for the same.
The Russian University successfully completes the clinical trial of the covid-19 vaccine. The first Moscow State medical University completes the trial.The director of the institute for translation medicine and biotechnology : Sputnik says that the first group of volunteers would be discharged on Wednesday and 2nd on 20thJuly.
The vaccine development plan determines the developers strategy. It includes the complexity of the epidemiological situationwith the virus and the possibility of scaling up production.The trials for the vaccine which has been started on June 18th is successfully completed by Sechenov University.
Moreover, the university confirms it safety. It is corresponding to the safety of those vaccines that are currently on the market as set by Lukashev.Tarasov says,” Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research centre which was able to participate in the creation of such important and complex product as drugs.”
Phase II of the vaccine trial, which is soon set to take place will test the efficiency and immunogenicity of the vaccine, i.e., see if the prototype actually develops the desired response enough to trigger the bad virus. Depending on the same, phase III will be decided.